Sign up for free insights newsletter
07

Shandong Xinhua Pharmaceutical Co Ltd

0719Hong Kong Stock Exchange

Need professional-grade analysis? Visit stockanalysis.com

HK$6.37
-0.31%
End of day
Market Cap

$9.58B

P/E Ratio

13.25

Employees

7,296

Dividend Yield

2.37%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino3.91-2.20-1.84-1.711.270.33-0.24
Calmar-7.13-2.20-1.750.670.16-1.25
Sharpe2.16-1.93-1.46-1.200.670.17-0.33
Omega1.620.600.740.781.171.120.98
Martin71.69-9.84-3.86-3.181.070.211.71
Ulcer0.393.796.868.0318.7149.3520.05

Shandong Xinhua Pharmaceutical Co Ltd (0719) Price Performance

Shandong Xinhua Pharmaceutical Co Ltd (0719) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at HKD6.37, down 0.31% from the previous close.

Over the past year, 0719 has traded between a low of HKD5.26 and a high of HKD9.05. The stock has gained 18.8% over this period. It is currently 29.6% below its 52-week high.

Shandong Xinhua Pharmaceutical Co Ltd has a market capitalization of $9.58B, with a price-to-earnings ratio of 13.25 and a dividend yield of 2.37%.

About Shandong Xinhua Pharmaceutical Co Ltd

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. It also provides ibuprofen bulk pharmaceutical products; and prepared Chinese herbal medicine for decoction, traditional Chinese medicine, chemical bulk drugs, chemical preparations, chemical raw materials, antibiotics, biochemical medicines, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc. In addition, the company offers raw materials and intermediates; internet data services, internet sales, and internet information services for pharmaceuticals and medical devices; veterinary drugs and fodders; bulk pharmaceutical and intermediates; steroid system apis and intermediates; and chemical raw materials. Further, the company produces and sells chemical products; exports and imports goods and technologies; and designs medical projects. Additionally, it engages in the property management, nonresidential real estate leasing, and housing leasing activities; certification and import and export business; electrical equipment engineering; installation and testing of chemical equipment; and manufacture of mechanical and electrical equipment, nonstandard equipment, as well as production and hardware and electrical equipment, and electrical installations equipment and manufacture; and sale of controller switching equipment. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.

Compare Shandong Xinhua Pharmaceutical Co Ltd

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
Hong Kong Stock Exchange
Currency
HKD
Country
Hong Kong

Financial Metrics

Revenue (TTM)
$8.75B
EBITDA
$927.71M
Profit Margin
3.31%
EPS (TTM)
0.45
Book Value
8.74

Technical Indicators

52 Week High
HK$9.46
52 Week Low
HK$5.23
50 Day MA
HK$6.74
200 Day MA
HK$7.19
Beta
0.01

Valuation

Trailing P/E
13.25
Forward P/E
12.33
Price/Sales
1.09
Price/Book
0.74
Enterprise Value
$9.75B